Where can I find the terms of Evotec SE’s share repurchase program?

The program is described in Exhibit 99.1, an announcement under EU Market Abuse Regulation and its Delegated Regulation.

Evotec SE files Form 6-K announcing share repurchase program

Q: Which annual report format does Evotec SE use?

Evotec SE files annual reports under Form 20-F.

Q: Who signed the report for Evotec SE?

It was signed by Christian Wojczewski, Chief Executive Officer.

Evotec SE filed a Form 6-K announcing that its management resolved on November 06, 2025 to implement a share repurchase program.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

Evotec SE filed a Form 6-K announcing that its management resolved on November 06, 2025 to implement a share repurchase program. The company states that the program is described in Exhibit 99.1, an announcement made pursuant to Article 5(1)(a) of Regulation (EU) No. 596/2014 and Article 2(1) of Delegated Regulation (EU) No. 2016/1052.

This is an administrative disclosure indicating the company’s decision to buy back shares, with specific terms set out in the accompanying exhibit.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Evotec SE (EVO) disclose in this Form 6-K?

Evotec SE reported it resolved to implement a share repurchase program, with details provided in Exhibit 99.1.

When did Evotec SE make the buyback decision?

The resolution to implement the share repurchase program was made on November 06, 2025.

Which annual report format does Evotec SE use?

Evotec SE files annual reports under Form 20-F.

Who signed the report for Evotec SE?

It was signed by Christian Wojczewski, Chief Executive Officer.

What regulatory references are cited for the announcement?

Article 5(1)(a) of Regulation (EU) No. 596/2014 and Article 2(1) of Delegated Regulation (EU) No. 2016/1052.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 11/06/2025 - 11:02 AM EST

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November, 2025

COMMISSION FILE NUMBER 001-34041

Evotec SE
(Translation of registrant’s name into English)

Essener Bogen 7

22419 Hamburg

Germany

Tel: +49 40 560810
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

On November 06, 2025, Evotec SE (the “Company”) resolved to implement a share repurchase program as described attached hereto as Exhibit 99.1.

EXHIBIT INDEX

Exhibit		Description of Exhibit
99.1		Announcement pursuant to Article 5(1)(a) of Regulation (EU) No. 596/2014 in conjunction with Article 2(1) of Delegated Regulation (EU) No. 2016/1052

SIGNATURE

Pursuant to the requirements, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Evotec SE

By:	/s/ Christian Wojczewski
	Name:	Christian Wojczewski
	Title:	Chief Executive Officer

Date: November 06, 2025

Source: View Original Filing on SEC EDGAR